Stock listing

NASDAQ:HSCS HeartSciences Inc. Stock

Home listing (NASDAQ) of HeartSciences Inc.

Follow HeartSciences Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HSCS

$1.81 USD -0.29 (-13.8%)

Close on Nov 20, 2026

Past year -37.8% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.77 – $2.05 USDNov 20, 2026
Volume
174,596 sharesNov 20, 2026
Market cap
$8.99M USDAt the close on Nov 20, 2026 · price × 4.97M shares outstanding
52-week range
$1.63 – $5.25 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$603,584 USDMedian day 98,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
HeartSciences Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:HSCS · Home$1.81 USD-0.29 (-13.8%)174,596$1.96$2.05$1.77$2.10Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:HSCS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.81-0.29-13.8%$1.96$2.05$1.77174,596
$2.10+0.04+1.9%$2.13$2.15$2.0015,659
$2.06-0.02-1.0%$2.12$2.19$2.0517,544
$2.08-0.045-2.1%$2.13$2.175$2.0529,846
$2.125-0.135-6.0%$2.21$2.31$2.0933,406
$2.26-0.035-1.5%$2.205$2.33$2.2086,303
$2.295-0.10-4.2%$2.525$2.525$2.06181,936
$2.395-0.315-11.6%$2.69$2.82$2.04230,194
$2.71-0.12-4.2%$2.78$2.94$2.6077,705
$2.83+0.16+6.0%$2.75$3.03$2.7576,388
$2.67-0.43-13.9%$3.06$3.06$2.6281,153
$3.10+0.15+5.1%$3.02$3.26$3.02100,553
$2.95-0.04-1.3%$3.156$3.156$2.8860,630
$2.99-0.32-9.7%$3.37$3.37$2.9769,839
$3.31-0.30-8.3%$3.57$3.57$3.3154,480
$3.61+0.24+7.1%$3.323$3.61$3.2575,784
$3.37+0.09+2.7%$3.27$3.415$3.18225,569
$3.28+0.10+3.1%$3.182$3.38$3.15110,558
$3.18+0.04+1.3%$3.14$3.274$3.01130,452
$3.14-0.03-0.9%$3.17$3.22$3.0721,800
$3.17-0.39-11.0%$3.41$3.445$3.1198,400
$3.56+0.43+13.7%$3.20$3.68$3.20236,000
$3.13+0.06+2.0%$3.02$3.32$3.0042,800
$3.07+0.05+1.7%$2.97$3.16$2.9385,400
$3.02-0.16-5.0%$3.18$3.27$3.00129,100
$3.18+0.16+5.3%$2.95$3.239$2.8971,600
$3.02-0.07-2.3%$3.10$3.165$2.95185,700
$3.09-0.21-6.4%$3.36$3.42$3.04590,700
$3.30+0.12+3.8%$3.19$3.37$3.0958,000
$3.18+0.14+4.6%$3.25$3.44$3.15109,300
$3.04-0.45-12.9%$3.40$3.435$3.02152,700
$3.49-0.28-7.4%$3.67$3.815$3.4975,300
$3.77-0.59-13.5%$3.79$3.88$3.368599,700
$4.36+0.06+1.4%$4.15$4.63$4.152,136,900
$4.30+0.41+10.5%$3.87$4.44$3.87178,000
$3.89-0.29-6.9%$4.15$4.24$3.80134,300
$4.18+0.13+3.2%$4.14$4.36$4.1172,900
$4.05-0.38-8.6%$4.40$4.48$3.97136,800
$4.43-0.30-6.3%$4.65$4.65$4.2999,700
$4.73+0.10+2.2%$4.78$5.00$4.6697,900
$4.63+0.11+2.4%$4.64$4.75$4.23125,900
$4.52-0.09-2.0%$4.56$5.03$4.45179,700
$4.61-0.07-1.5%$4.76$5.21$4.55264,400
$4.68-0.52-10.0%$5.25$5.25$4.62247,400
$5.20+0.36+7.4%$4.79$5.21$4.68174,400
$4.84+1.05+27.7%$3.90$4.89$3.805386,200
$3.79+0.35+10.2%$3.45$3.94$3.4389,200
$3.44-0.10-2.8%$3.50$3.50$3.2565,700
$3.54+0.15+4.4%$3.39$3.60$3.3381,000
$3.39-0.12-3.4%$3.40$3.69$3.31100,700
$3.51-0.61-14.8%$3.86$4.015$3.38222,000
$4.12+0.04+1.0%$4.31$4.32$3.88124,700
$4.08+0.35+9.4%$3.98$4.35$3.905288,900
$3.73+0.37+11.0%$3.34$3.83$3.21179,600
$3.36+0.35+11.6%$3.12$3.45$2.96176,600
$3.01-0.11-3.5%$3.12$3.189$3.0025,400
$3.12-0.03-1.0%$3.19$3.28$3.09569,700
$3.15+0.12+4.0%$3.01$3.20$2.9556,000
$3.03-0.09-2.9%$3.09$3.14$2.9045,700
$3.12+0.13+4.3%$2.94$3.25$2.90155,900
$2.99-0.01-0.3%$2.90$3.03$2.82581,400
$3.00+0.24+8.7%$2.80$3.04$2.7096,600
$2.76-0.04-1.4%$2.91$3.20$2.70718,100
$2.80+0.29+11.6%$2.53$2.87$2.47198,800
$2.51-0.035-1.4%$2.49$2.617$2.37231,100

Splits

1 split · NASDAQ:HSCS · every price before a split is adjusted for it

DayRatioWhat
1-for-100Consolidation
Ticker
NASDAQ:HSCS
Asset type
Stock
Sector
Health care
Industry
Health care services
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All HeartSciences Inc. news

HeartSciences Inc. on 6ix

Sector
Health care
Industry
Health care services
News releases
23 in the last 12 months · 77 in all · newest Nov 20, 2026 · oldest 2022
Decks
4 decks · latest Jun 23, 2026

Where HeartSciences Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HSCS · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HSCSBOATSUnited StatesUSD

Valuation

EV/sales 1,984× against a median of 3.3×: the highest of 11 Health care services companies shown. Statements: 4 quarters to Jul 31, 2026 · price Nov 20, 2026

Enterprise value
$8.96M USD
P/E
Loss
EV/sales
1,984×
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
Negative equity
Gross margin
60.9%
Operating margin
Revenue too small
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
1.23

Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
HeartSciences Inc. · NASDAQ:HSCSUS$8.99MUS$8.96Mn/a1,984×n/an/an/an/a1.23
Morefield Group N.V. · EURONEXT:MOREUS$10.12MUS$75.51M2.2×0.4×2.6×0.4×2.6%3.1×n/a
Concord Medical Services Holdings Ltd. · NYSE:CCMUS$9.99MUS$509.8Mn/a7.4×n/an/a−20.2%n/a0.49
Vidavo SA · ATHEX:VIDAVOUS$9.78MUS$8.25M15.0×3.5×9.2×4.1×27.4%0.0×n/a
AIML Innovations Inc · CSE:AIMLUS$9.68MUS$11.23Mn/a369×n/an/an/an/a0.33
UCrest Bhd · MYX:UCRESTUS$9.05MUS$6.78M138×2.0×34.7×0.9×1.9%0.0×n/a
PainChek Ltd · ASX:PCKUS$8.86MUS$7.71Mn/a3.1×n/an/a−238.8%n/an/a
Good Fellow Healthcare Holdings Limited · HKEX:8143US$8.53MUS$6.81Mn/a2.7×n/a8.2×−62.4%0.1×n/a
KDA Group Inc. · TSXV:KDAUS$8.51MUS$8.34Mn/a28.6×n/a2.0×n/a0.0×-0.76
InteliCare Holdings Limited · ASX:ICRUS$8.05MUS$8.25Mn/a13.0×n/an/a−234.6%n/an/a
SEI Medical Public Co., Ltd. · SET:SEIUS$7.91MUS$4.28M8.7×0.3×2.5×0.9×7.5%0.0×n/a
Median of the othersUS$8.96MUS$8.25M11.9×3.3×5.9×1.5×−9.1%0.0×0.33

Forecasts

1 buy · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
12.00 USD · Analysts' mean
EPS, year to Apr 2027
-2.46 · 1 analyst
Revenue, year to Apr 2027
17.1K · 1 analyst

Team and board

Officers

OfficerRole
Andrew SimpsonChairman and CEO / Board Member
Danielle WatsonChief Financial Officer
Aaron PetersonVP, Research & Development
Isabella SchmittVP, Clinical & Regulatory Affairs
Jason DomaskVP of Software Engineering & MyoVista Insights™ Product Owner

Board

DirectorRole
Andrew SimpsonChairman and CEO / Board Member
Brian SzymczakBoard Member
Bruce BentBoard Member
David R. WellsBoard Member

Events

Next results
Dec 21, 2026 (expected)
QuarterResultsShare move
Q1 2027Sep 14, 2026 · After close−2.8%
Q4 2026Jul 23, 2026 · After close−2.0%
Q3 2026Mar 16, 2026 · After close−0.4%
Q2 2026Dec 15, 2025 · After close−6.5%
Q1 2026Sep 11, 2025 · After close−10.0%
Q4 2025Jul 24, 2025 · After close+0.3%
Q3 2025Mar 13, 2025 · After close−3.6%
Q2 2025Dec 16, 2024 · After close0.0%
Q1 2025Sep 12, 2024 · After close+9.0%
Q4 2024Jul 17, 2024−3.5%
All 18 quarters
QuarterResultsShare move
Q3 2024Mar 14, 2024 · After close+1.6%
Q2 2024Dec 14, 2023 · After close+12.0%
Q1 2024Sep 14, 2023 · After close+3.9%
Q4 2023Jul 19, 2023 · Before open−5.3%
Q3 2023Mar 16, 2023 · After close+9.9%
Q2 2023Dec 15, 2022 · After close−1.5%
Q1 2023Sep 12, 2022 · After close+4.8%
Q4 2022Jul 29, 2022 · After close+5.1%

Open Events

Decks

DeckKindSlidesDate
Merger or Acquisition (June 2026)Merger or acquisition35 slidesJun 23, 2026
Merger or Acquisition (June 2026)Merger or acquisition11 slidesJun 23, 2026
Merger or Acquisition (June 2026)Merger or acquisition35 slidesJune 2026
Heart Test Laboratories — IPO Roadshow (June 2022)IPO roadshow25 slidesJun 6, 2022

Open Decks

Financings

RaiseDate
Private placement of shares of common stock
Closed: US$1M in the latest tranche · US$2.43 a share
Buyers: Fortitude Mining Holdings, Inc. (approximately $1.0 million of shares of common stock)
Use of proceeds: Working capital and strengthening the balance sheet ahead of the proposed business combination
Sep 15, 2026
At-the-market programme of common stock
Tranche closed: US$1.2M raised
Sep 15, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as Heart Test Laboratories, Inc. Priced at US$4.25 a unit on Jun 17, 2022.

Price
US$4.25 a unit
Units offered
1,500,000 units
Offering size
US$6.4 million
Underwriter
The Benchmark Company
Units delivered
On or about Jun 17, 2022

Steps

StepWhen
Draft sent to the SEC in confidenceFeb 28, 2022
Filed publiclyMay 17, 2022
Amended 3 timesNewest Jun 13, 2022
Shares registered with an exchangeJun 14, 2022
Declared effective by the SECJun 14, 2022
Final prospectus, with the priceJun 17, 2022

Open IPO · From the cover of the final prospectus (424B4) filed Jun 17, 2022

Financials

Annual, in USD

Income statement

LineFY2026FY2025FY2024FY2023FY2022
Revenue4.32K4.35K18.6K5.15K14.4K
Cost of revenue1.77K1.88K6.08K2.80K7.89K
Gross profit2.55K2.47K12.5K2.35K6.48K
Research and development2.84M4.39M2.88M2.46M3.00M
Selling, general and administrative5.58M3.97M3.44M3.65M1.71M
Operating income-8.41M-8.35M-6.31M-6.11M-4.71M
Depreciation and amortization27.8K37.6K27.9K26.9K26.6K
EBITDA-8.39M-8.31M-6.28M-6.09M-4.68M
Interest expense753.0K500.5K354.1K243.2K371.6K
Income tax00
Net income-9.14M-8.77M-6.61M-6.35M-4.83M
Earnings per share, basic-3.48-9.34-18.74-80.00-1.45
Earnings per share, diluted-9.34-18.74-80.00-1.45

Balance sheet

LineFY2026FY2025FY2024FY2023FY2022
Cash and equivalents1.66M1.10M5.81M1.66M918.3K
Receivables4.35K2.32K
Inventory655.6K650.3K629.2K676.4K674.1K
Current assets2.58M2.17M7.35M2.70M1.93M
Property, plant and equipment39.3K63.5K98.0K61.4K70.0K
Total assets5.26M4.22M9.50M3.29M2.09M
Accounts payable318.3K318.7K448.2K631.4K694.7K
Current liabilities4.86M3.70M1.75M1.83M3.47M
Total liabilities5.04M4.02M2.19M3.06M8.15M
Shareholders' equity226.1K205.2K7.32M230.6K-6.06M
Shares outstanding3.19M1.12M676.6K101.3K3.32M

Cash flow

LineFY2026FY2025FY2024FY2023FY2022
Cash from operations-7.43M-7.41M-6.07M-5.77M-3.64M
Capital spending-3.55K-3.16K-64.5K-18.3K-1.93K
Free cash flow-7.43M-7.42M-6.13M-5.79M-3.65M
Cash from investing-44.5K-30.2K-125.3K-18.3K-1.93K
Cash from financing8.03M2.73M10.3M6.53M3.84M
Change in cash558.7K-4.71M4.15M742.2K194.8K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 19, 2026Meeting outcomeSEC
424B5 · ProspectusNov 19, 2026Offer documentSEC
DEFA14A · Additional proxy materialNov 19, 2026Meeting noticeSEC
8-K · Current reportNov 19, 2026Material contractSEC
DEFA14A · Additional proxy materialNov 19, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveNov 19, 2026Other filingsSEC
DEFA14A · Additional proxy materialNov 18, 2026Meeting noticeSEC
S-3/A · Registration statement, amendedNov 17, 2026Offer documentSEC
DEFA14A · Additional proxy materialNov 17, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 13, 2026Meeting noticeSEC
Show 200 filings
FilingDateTypeFiled with
DEFA14A · Additional proxy materialNov 13, 2026Meeting noticeSEC
8-K/A · Current report, amendedNov 13, 2026Current reportSEC
DEFA14A · Additional proxy materialNov 12, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 10, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 10, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 10, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 9, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 6, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 6, 2026Meeting noticeSEC
8-K · Current reportNov 6, 2026Current reportSEC
DEFA14A · Additional proxy materialNov 5, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 4, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 3, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialNov 2, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 30, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 29, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 28, 2026Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeOct 28, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialOct 27, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 26, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 26, 2026Meeting noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 23, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialOct 21, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 19, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 19, 2026Meeting noticeSEC
DEFM14AOct 19, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialOct 15, 2026Meeting noticeSEC
424B5 · ProspectusOct 9, 2026Offer documentSEC
DEFA14A · Additional proxy materialOct 6, 2026Meeting noticeSEC
8-K · Current reportOct 6, 2026Current reportSEC
DEFA14A · Additional proxy materialOct 6, 2026Meeting noticeSEC
PRER14AOct 5, 2026Other filingsSEC
DEFA14A · Additional proxy materialOct 2, 2026Meeting noticeSEC
8-K · Current reportOct 2, 2026Material contractSEC
DEFA14A · Additional proxy materialSep 30, 2026Meeting noticeSEC
S-3 · Registration statementSep 25, 2026Offer documentSEC
DEFA14A · Additional proxy materialSep 24, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 21, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 18, 2026Meeting noticeSEC
PRER14ASep 17, 2026Other filingsSEC
DEFA14A · Additional proxy materialSep 17, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 17, 2026Meeting noticeSEC
8-K · Current reportSep 17, 2026Current reportSEC
DEFA14A · Additional proxy materialSep 16, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 15, 2026Meeting noticeSEC
8-K · Current reportSep 15, 2026ResultsSEC
DEFA14A · Additional proxy materialSep 15, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 14, 2026Meeting noticeSEC
10-Q · Quarterly reportSep 14, 2026Quarterly reportSEC
DEFA14A · Additional proxy materialSep 11, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 10, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 10, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 9, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 9, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 8, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 8, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 4, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 4, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 3, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 2, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialSep 1, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 31, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 31, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 28, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 27, 2026Meeting noticeSEC
S-8 · Registration statement for employee plansAug 25, 2026Offer documentSEC
DEFA14A · Additional proxy materialAug 25, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 24, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 21, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 20, 2026Meeting noticeSEC
8-K · Current reportAug 20, 2026Current reportSEC
DEFA14A · Additional proxy materialAug 19, 2026Meeting noticeSEC
8-K/A · Current report, amendedAug 19, 2026Current reportSEC
DEFA14A · Additional proxy materialAug 19, 2026Meeting noticeSEC
8-K · Current reportAug 19, 2026Current reportSEC
SCHEDULE 13D · Big-stake noticeAug 18, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialAug 18, 2026Meeting noticeSEC
8-K · Current reportAug 18, 2026Material contractSEC
DEFA14A · Additional proxy materialAug 7, 2026Meeting noticeSEC
8-K · Current reportAug 7, 2026Current reportSEC
DEFA14A · Additional proxy materialAug 6, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialAug 4, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJul 30, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJul 29, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJul 29, 2026Meeting noticeSEC
8-K · Current reportJul 29, 2026ResultsSEC
DEFA14A · Additional proxy materialJul 28, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJul 28, 2026Meeting noticeSEC
PREM14AJul 27, 2026Other filingsSEC
DEFA14A · Additional proxy materialJul 27, 2026Meeting noticeSEC
8-K/A · Current report, amendedJul 27, 2026Current reportSEC
DEFA14A · Additional proxy materialJul 27, 2026Meeting noticeSEC
8-K · Current reportJul 27, 2026Material contractSEC
DEFA14A · Additional proxy materialJul 23, 2026Meeting noticeSEC
8-K · Current reportJul 23, 2026Current reportSEC
10-K · Annual reportJul 23, 2026Annual reportSEC
DEFA14A · Additional proxy materialJul 22, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJul 10, 2026Meeting noticeSEC
8-K · Current reportJul 10, 2026Management or board changeSEC
4 · Change in ownershipJul 9, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJun 26, 2026Meeting noticeSEC
8-K · Current reportJun 26, 2026Management or board changeSEC
DEFA14A · Additional proxy materialJun 26, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJun 26, 2026Meeting noticeSEC
DEFA14A · Additional proxy materialJun 25, 2026Meeting noticeSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
DEFA14A · Additional proxy materialJun 24, 2026Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeJun 24, 2026Big-stake noticeSEC
DEFA14A · Additional proxy materialJun 23, 2026Meeting noticeSEC
8-K · Current reportJun 23, 2026Current reportSEC
DEFA14A · Additional proxy materialJun 23, 2026Meeting noticeSEC
8-K · Current reportJun 23, 2026Material contractSEC
253G2Jun 1, 2026Other filingsSEC
8-K · Current reportMay 6, 2026Meeting outcomeSEC
QUALIFApr 20, 2026Other filingsSEC
253G2Apr 17, 2026Other filingsSEC
1-A POSApr 10, 2026Other filingsSEC
8-K · Current reportApr 3, 2026Management or board changeSEC
DEFA14A · Additional proxy materialMar 19, 2026Meeting noticeSEC
DEF 14A · Proxy statementMar 17, 2026Meeting noticeSEC
8-K · Current reportMar 16, 2026ResultsSEC
10-Q · Quarterly reportMar 16, 2026Quarterly reportSEC
PRE 14A · Preliminary proxy statementMar 6, 2026Meeting noticeSEC
8-K · Current reportJan 16, 2026Material contractSEC
4 · Change in ownershipJan 12, 2026Insider tradeSEC
4 · Change in ownershipJan 12, 2026Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
4 · Change in ownershipDec 22, 2025Insider tradeSEC
8-K · Current reportDec 16, 2025Material contractSEC
8-K · Current reportDec 15, 2025ResultsSEC
10-Q · Quarterly reportDec 15, 2025Quarterly reportSEC
4 · Change in ownershipNov 28, 2025Insider tradeSEC
8-K · Current reportNov 28, 2025Management or board changeSEC
S-8 · Registration statement for employee plansNov 5, 2025Offer documentSEC
8-K · Current reportOct 1, 2025Material contractSEC
8-K · Current reportSep 17, 2025Current reportSEC
8-K · Current reportSep 11, 2025ResultsSEC
10-Q · Quarterly reportSep 11, 2025Quarterly reportSEC
8-K · Current reportSep 5, 2025Current reportSEC
8-K · Current reportAug 22, 2025Current reportSEC
424B5 · ProspectusAug 4, 2025Offer documentSEC
8-K · Current reportAug 4, 2025Material contractSEC
4 · Change in ownershipJul 30, 2025Insider tradeSEC
8-K · Current reportJul 30, 2025Current reportSEC
144 · Notice of proposed saleJul 29, 2025Other filingsSEC
8-K · Current reportJul 24, 2025ResultsSEC
10-K · Annual reportJul 24, 2025Annual reportSEC
8-K · Current reportJul 21, 2025Current reportSEC
4 · Change in ownershipJul 14, 2025Insider tradeSEC
8-K · Current reportJul 14, 2025Material contractSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
4 · Change in ownershipJul 11, 2025Insider tradeSEC
8-K · Current reportJul 1, 2025Current reportSEC
8-K · Current reportJun 4, 2025Current reportSEC
8-K · Current reportJun 3, 2025Material contractSEC
8-K · Current reportJun 3, 2025Current reportSEC
8-K · Current reportMay 28, 2025Current reportSEC
8-K · Current reportMay 19, 2025Current reportSEC
253G2May 15, 2025Other filingsSEC
8-K · Current reportMar 21, 2025Current reportSEC
8-K · Current reportMar 13, 2025ResultsSEC
10-Q · Quarterly reportMar 13, 2025Quarterly reportSEC
253G2Mar 11, 2025Other filingsSEC
QUALIFMar 11, 2025Other filingsSEC
CORRESP · Letter to the SECMar 6, 2025Other filingsSEC
1-A/AFeb 28, 2025Other filingsSEC
UPLOAD · Letter from the SECFeb 21, 2025Other filingsSEC
1-AFeb 12, 2025Other filingsSEC
4 · Change in ownershipJan 23, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
4 · Change in ownershipJan 21, 2025Insider tradeSEC
8-K · Current reportJan 21, 2025Management or board changeSEC
RW · Request to withdraw a registrationDec 19, 2024Other filingsSEC
8-K · Current reportDec 17, 2024Current reportSEC
RW · Request to withdraw a registrationDec 17, 2024Other filingsSEC
8-K · Current reportDec 16, 2024ResultsSEC
10-Q · Quarterly reportDec 16, 2024Quarterly reportSEC
8-K · Current reportNov 8, 2024Meeting outcomeSEC
8-K/A · Current report, amendedOct 21, 2024Current reportSEC
8-K · Current reportOct 18, 2024Current reportSEC
S-1/A · Registration statement, amendedSep 27, 2024Offer documentSEC
DEFA14A · Additional proxy materialSep 26, 2024Meeting noticeSEC
DEF 14A · Proxy statementSep 18, 2024Meeting noticeSEC

This page holds 200 of 366 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from HeartSciences Inc.’s releases · as of Sep 15, 2026

Common shares
4,969,283
Fully diluted
4,969,283

Fully diluted

LineSharesAs of
Common shares4,969,283Aug 12, 2026

Share count over time

CountShares
Aug 12, 20264,969,283

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Vanguard71,3521.5%US$298KSep 30, 2026
TFB Advisors LLC29,7400.62%US$124KSep 30, 2026
Geode Capital29,5600.62%US$124KSep 30, 2026
Astoria Strategic Wealth, Inc.18,9270.39%US$79,115Sep 30, 2026
Jane Street18,3330.38%US$76,632Sep 30, 2026
Tradition Wealth Management, LLC16,8190.35%US$70,303Sep 30, 2026
Citigroup Inc13,4470.28%US$56,208Sep 30, 2026
UBS12,7740.27%US$53,395Sep 30, 2026
Citadel12,1210.25%US$50,666Sep 30, 2026
Morgan Stanley1,5000.03%US$6,270Sep 30, 2026
All 17 holders
HolderSharesOf the companyValueAs of
Fidelity7360.02%US$3,075Sep 30, 2026
Federation des caisses Desjardins du Quebec7000.01%US$2,926Sep 30, 2026
Osaic Holdings, Inc.50<0.01%US$202Sep 30, 2026
Allworth Financial LP50<0.01%US$209Sep 30, 2026
Caitong International Asset Management Co., Ltd27<0.01%US$113Sep 30, 2026
Dunhill Financial, LLC4<0.01%US$376Sep 30, 2026
Barclays1<0.01%US$4Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Fidelity Extended Market Index Fund19,3670.40%US$32,149May 31, 2026
Vanguard Extended Market Index Fund17,9680.37%US$45,100Jun 30, 2026
Fidelity Series Total Market Index Fund2,6930.06%US$4,470May 31, 2026
Fidelity Total Market Index Fund2,2490.05%US$3,733May 31, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
David R. Wells
Other companies: Fusemachines Inc. (Chief Financial Officer · Since at least Sep 1, 2026); Functional Brands, Inc. (Chief Financial Officer, Director · Since at least May 18, 2026); Envoy Medical, Inc. (Chief Financial Officer · Sep 29, 2023 – Oct 15, 2023 · Past); ENDRA Life Sciences Inc. (Chief Financial Officer · May 8, 2017 – Apr 5, 2021 · Past); Sionix Corporation (President, CFO, Director · Dec 16, 2009 – May 7, 2012 · Past)
Board Member · Since at least Dec 28, 2022
Bruce Bent
Other companies: Astro Aerospace Ltd (Director · Mar 14, 2018 – Mar 4, 2021 · Past)
Board Member · Since at least Jun 14, 2022
Aaron PetersonVP, Research & Development · Since at least Nov 4, 2026
Andrew SimpsonChairman and CEO / Board Member · Since at least Jun 14, 2022
Brian SzymczakDirector · Since at least Jun 14, 2022
Danielle WatsonChief Financial Officer · Since at least Nov 4, 2026
Isabella SchmittVP, Clinical & Regulatory Affairs · Since at least Nov 4, 2026
Jason DomaskVP of Software Engineering & MyoVista Insights™ Product Owner · Since at least Nov 4, 2026
Mark T HilzSee Remarks · Since at least Jun 14, 2022
Patrick KanouffDirector · Jun 14, 2022 – Jun 14, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about HeartSciences Inc.